Eurofarma is the best national pharmaceutical company in the Best Award of IstoÉ Dinheiro
Published in: September 14, 2018
and updated in: November 4, 2021
Listen to the text
Stop the audio
São Paulo, September 2018 - The IstoÉ Dinheiro magazine published its annual "Melhores da Dinheiro" award, a reference in the Brazilian publishing market, which evaluates the performance and work of companies in 23 sectors of the economy, according to good practices in financial management, corporate governance, social responsibility, human resources, innovation and quality.
Eurofarma was the 2nd general position of the Pharmaceutical, Hygiene and Cleaning sector and the first among the national pharmaceutical companies. The company also ranked among the three best placed in four of the five dimensions evaluated, winning 1st place in Corporate Governance, 2nd place in Social Responsibility and Innovation and Quality, 3rd position in Human Resources and 5th place in Financial Sustainability. In the general ranking of the sector, Roche won the 1st place.
About Eurofarma Brazil
With 46 years of existence, the Eurofarma Group is the first Brazilian pharmaceutical multinational with 100% national capital, being recognized by the medical community and society for promoting access to health and quality of life with a fair price, quality and innovation treatments.
Present in 20 countries, it operates in the Medical Prescription and Prescription-Free, Generic, Hospital, Bids, Oncology, Veterinary and Services to Third-party segments. In Brazil, the portfolio is represented by 335 brands in 844 presentations, including 28 medical specialties and 148 therapeutic classes.
For more information, visit www.eurofarma.com.br
Facebook: @eurofarma | LinkedIn: @eurofarma | Instagram:@eurofarma_br
Information to the press:
Stephanie Van Sebroeck +55 11 5090-8600 ext.8369 – stephanie@gaspar.com.br
Guilherme Gaspar +55 11 3065-3045 – guilherme@gaspar.com.br
Eurofarma was the 2nd general position of the Pharmaceutical, Hygiene and Cleaning sector and the first among the national pharmaceutical companies. The company also ranked among the three best placed in four of the five dimensions evaluated, winning 1st place in Corporate Governance, 2nd place in Social Responsibility and Innovation and Quality, 3rd position in Human Resources and 5th place in Financial Sustainability. In the general ranking of the sector, Roche won the 1st place.
About Eurofarma Brazil
With 46 years of existence, the Eurofarma Group is the first Brazilian pharmaceutical multinational with 100% national capital, being recognized by the medical community and society for promoting access to health and quality of life with a fair price, quality and innovation treatments.
Present in 20 countries, it operates in the Medical Prescription and Prescription-Free, Generic, Hospital, Bids, Oncology, Veterinary and Services to Third-party segments. In Brazil, the portfolio is represented by 335 brands in 844 presentations, including 28 medical specialties and 148 therapeutic classes.
For more information, visit www.eurofarma.com.br
Facebook: @eurofarma | LinkedIn: @eurofarma | Instagram:@eurofarma_br
Information to the press:
Stephanie Van Sebroeck +55 11 5090-8600 ext.8369 – stephanie@gaspar.com.br
Guilherme Gaspar +55 11 3065-3045 – guilherme@gaspar.com.br